Acadia Pharmaceuticals (ACAD) Treasury Shares (2012 - 2013)
Acadia Pharmaceuticals' (ACAD) quarterly Treasury Shares came in at $1.9 million in Q3 2013, down 65.3% quarter-over-quarter from $5.3 million in Q2 2013.
Acadia Pharmaceuticals (ACAD) Treasury Shares (2012 - 2013) Analysis & Trends
Acadia Pharmaceuticals' Treasury Shares history runs 2 years deep, the most recent figure standing at $1.9 million for Q3 2013.
- On a quarterly basis, Treasury Shares changed N/A year-over-year to $1.9 million in Q3 2013; TTM through Sep 2013 was $1.9 million, a N/A change from a year earlier, with the FY2012 full-year figure at $5.3 million, changed N/A from the prior year.
- Treasury Shares retreated to $1.9 million in Q3 2013 per ACAD's latest filing, from $5.3 million in the prior quarter.
- Across five years, Treasury Shares topped out at $5.3 million in Q4 2012 and bottomed at $1.9 million in Q3 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Acadia Pharmaceuticals | 4.23 Bn | 3.38 Bn | 243.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2013 | 1.86 Mn |
| Sep 30, 2013 | 1.86 Mn |
| Jun 30, 2013 | 5.35 Mn |
| Jun 30, 2013 | 5.35 Mn |
| Mar 31, 2013 | 5.35 Mn |
| Mar 31, 2013 | 5.35 Mn |
| Dec 31, 2012 | 5.35 Mn |
| Dec 31, 2012 | 5.35 Mn |